Please wait while we load the requested 8-K report or click the link below:
https://last10k.com/sec-filings/report/1098880/000106299319001216/form8k.htm
March 2023
March 2023
February 2023
July 2022
May 2022
March 2022
December 2021
September 2021
August 2021
August 2021
Please wait while we load the requested 8-K report or click the link below:
https://last10k.com/sec-filings/report/1098880/000106299319001216/form8k.htm
Compare this 8-K Corporate News to its predecessor by reading our highlights to see what text and tables were removed , added and changed by Intelgenx Technologies Corp..
Intelgenx Technologies Corp.'s Definitive Proxy Statement (Form DEF 14A) filed after their 2019 10-K Annual Report includes:
Ticker: IGXTEvents:
CIK: 1098880
Form Type: 8-K Corporate News
Accession Number: 0001062993-19-001216
Submitted to the SEC: Fri Mar 08 2019 5:00:46 PM EST
Accepted by the SEC: Fri Mar 08 2019
Period: Wednesday, November 28, 2018
Industry: Pharmaceutical Preparations